Cite
HARVARD Citation
Diefenbach, C. et al. (n.d.). SAFETY AND EFFICACY OF COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB IN RELAPSED / REFRACTORY HODGKIN LYMPHOMA: a TRIAL OF THE ECOG‐ACRIN CANCER RESEARCH GROUP (E4412). Hematological oncology. pp. 84-85. [Online].